|
|
Drugs for Salivary Gland Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 417)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Cyclosporine | approved, investigational, vet_approved | Phase 4, Phase 2 | 922 | 79217-60-0, 59865-13-3 | 5284373, 6435893 | 1c5f 1cyn 30024_FLUKA 30024_SIGMA 59865-13-3 79217-60-0 AC1L1EQW AC1NQXJE AC1NR4C4 AC1NUQK3 AC1NUZNC AC1O5KOG AC1Q2UDG Ambap59865-13-3 Ambotz59865-13-3 Antibiotic S 7481F1 BMT-ABA-SAR-MLE-VAL-MLE-ALA-ALA-MLE-MLE-MVA BMT-ABA-SAR-MLE-VAL-MLE-ALA-DAL-MLE-MLE-MVA BPBio1_000496 BRD-A64290322-001-01-6 BRD-A69815203-001-04-3 BRD-K13533483-001-03-0 BSPBio_000450 BSPBio_001596 BSPBio_003186 C 3662 C05086 C1832_SIGMA C3662_SIGMA C62H111N11O12 CB-01-09 MMX CHEBI:106343 CHEBI:328305 CHEBI:4031 CHEMBL160 CHEMBL386389 CHEMBL532318 CID2909 CID5280754 CID5284373 CID5458585 CID5497195 CID6435893 CSA CYCLOSPORIN A (SEE ALSO TRANSGENIC MODEL EVALUATION (CYCLOSPORIN A)) CYCLOSPORIN A, USP Ciclosporin Ciclosporin (JP15) Ciclosporina Ciclosporine Ciclosporinum Cipol N Cipol-N Consupren Consupren S CsA CsA & IFN.alpha. CyA Cyclokat Cyclosporin Cyclosporin A Cyclosporin A & IFN.alpha. Cyclosporin A Implant Cyclosporin A, Tolypocladium inflatum Cyclosporine (USP) Cyclosporine A Cyclosporine [USAN] D00184 DE-076 DivK1c_000871 EU-0100242 Equoral GNF-Pf-2808 Gengraf Gengraf (TN) HMS1569G12 HMS1791P18 HMS1921L20 HMS1989P18 HMS2089A09 HMS2092F06 HMS502L13 Helv Chim Acta 60: 1568 (1977) | I06-0379 I06-0966 IDI1_000871 KBio1_000871 KBio2_000780 KBio2_003348 KBio2_005916 KBio3_002686 KBioGR_001898 KBioSS_000780 LMPK14000003 LS-257 LS-58836 Lopac0_000242 MLS000028376 MLS001333756 MLS002153454 MLS002207033 Mitogard Modusik-A MolPort-000-760-988 MolPort-005-934-008 MolPort-006-705-994 NCGC00093704-01 NCGC00093704-02 NCGC00093704-03 NCGC00093704-04 NCGC00093704-05 NCGC00093704-06 NCGC00093704-07 NCGC00093704-08 NCGC00164258-01 NCGC00164258-02 NINDS_000871 NSC290193 Neoplanta Neoral Neoral (TN) NeuroSTAT Nova-22007 OL 27-400 OL-27400 OLO-400 Papilock Prestwick2_000435 Prestwick3_000435 Prestwick_731 Pulminiq Ramihyphin A Restasis Restasis (TN) S-Neoral S1514_Selleck SDZ-OXL 400 SMR000058578 SPBio_001467 SPECTRUM1502202 ST-603 Sandimmun Sandimmun Neoral Sandimmune Sandimmune (TN) Sandimmune, Gengraf, Restasis, Atopica, Sangcya, Cyclosporine Sang-2000 Sang-35 SangCyA Sangcya Sigmasporin Sigmasporin Microoral Spectrum2_001484 Spectrum3_001593 Spectrum4_001279 Spectrum5_001628 Spectrum_000300 TRANSGENIC MODEL EVALUATION (CYCLOSPORIN A) Vekacia Zyclorin cyclophorine cyclosporin A cyclosporine from Tolypocladium inflatum (Trichoderma polysporin) nchembio.184-comp6 nchembio.301-comp5 nchembio.342-comp1 | |
| | 2 | | Epinephrine | approved, vet_approved | Phase 4, Phase 2, Phase 3, Phase 1 | 985 | 51-43-4 | 5816 | (-)-(R)-Epinephrine (-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol (-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol (-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol (-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol (-)-Adrenalin (-)-Adrenaline (-)-Epinephrine (-)-R-Epinephrine (R)-(-)-Adnephrine (R)-(-)-Adrenaline (R)-(-)-Epinephrine (R)-(-)-Epirenamine (R)-(−)-adrenaline (R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol (R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol (R)-Adrenaline (R)-Epinephrine (−)-adrenaline 02252_FLUKA 1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol 1-Adrenalin 1-Epinephrine 4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol 4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol 51-43-4 51-43-4 (FREE BASE) 51028-73-0 A0173 AC-13188 AC1L1L7B ADR ADRENALINE ADROP AI3-19015 Adnephrine Adrenal Adrenalin Adrenalin (TN) Adrenalin in Oil Adrenalin-Medihaler Adrenalina Adrenalina [DCIT] Adrenaline Adrenaline (JP15) Adrenaline/Epinephrine Adrenalinum Adrenamine Adrenan Adrenapax Adrenasol Adrenatrate Adrenine Adrenodis Adrenohorma Adrenosan Adrenutol Adrin Adrine Ana-Guard Ana-Kit Antiasthmatique Asmatane Mist Asthma meter mist Asthma-nefrin Asthmahaler Mist Asthmanefrin Astmahalin Astminhal BIDD:GT0119 Balmadren Bernarenin Biorenine Bosmin Brevirenin Bronkaid Bronkaid Mist Bronkaid Suspension Mist Bupivacaine Hcl and Epinephrine C00788 CCRIS 4812 CHEBI:28918 CHEMBL679 CID5816 Chelafrin Citanest Forte Corisol D-Epifrin D-Epinephrine D00095 DB00668 Drenamist Dylephrin Dyspne-Inhal E4250_SIGMA EINECS 200-098-7 EPI E Z PEN JR EPIPEN E Z PEN EPIPEN JR Epi EZ Pen Jr Epifrin Epiglaufrin Epinefrin Epinefrin [Czech] Epinefrina Epinefrina [INN-Spanish] Epinephran Epinephrin Epinephrine Epinephrine (USP) Epinephrine (USP/INN) Epinephrine [USAN:INN:JAN] Epinephrine hydrochloride Epinephrinum Epinephrinum [INN-Latin] Epipen Epipen (TN) Epipen Auto-Injector Epipen EZ Pen Epipen Jr. Epipen Jr. Auto-Injector Epirenamine Epirenan Epirenin Epitrate Eppy Esphygmogenina Exadrin | Glaucon Glaucosan Glauposine Glycirenan HSCI1_000215 HSDB 4289 Haemostasin Haemostatin Hektalin Hemisine Hemostasin Hemostatin Hypernephrin Hyporenin IOP Intranefrin Iontocaine Isoptoepinal Kidoline L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol L-Adrenaline L-Adrenaline Base L-Epinehphrine L-Epinephrine L-Epirenamine L-Methylaminoethanolcatechol L-epinephrine LS-156 Levo-Methylaminoethanolcatechol Levoadrenaline Levoepinephrine Levorenen Levorenin Levorenine Levoreninum Lopac-E-4642 Lyodrin Lyophrin Medihaler-Epi Metanephrin Methylaminoethanolcatechol Methylarterenol Micronefrin Micronephrine MolPort-002-051-368 Mucidrina Myosthenine Mytrate NCGC00015417-01 NCGC00142615-01 NCGC00142615-03 NCGC00142615-04 NCGC00142615-05 NCGC00142615-06 NCGC00142615-07 NSC 62786 NSC62786 Nephridine Nieraline PDSP1_001120 PDSP2_001104 Paranephrin Primatene Primatene Mist R-(-)-Epinephrine R-Adrenaline RCRA waste no. P042 Racemic Epinephrine Racepinephrine Rcra waste number P042 Renagladin Renaglandin Renaglandulin Renaleptine Renalina Renoform Renostypricin Renostypticin Renostyptin SMP1_000227 ST069368 SUS-PHRINE SULFITE-FREE Scurenaline Septocaine Simplene Sindrenina Soladren Sphygmogenin Stryptirenal Styptirenal Supracapsulin Supradin Supranefran Supranephrane Supranephrine Supranol Suprarenaline Suprarenin Suprel Surenine Surrenine Sus-Phrine Sus-phrine Susphrine Sympathin I Takamina Takamine Tokamina Tonogen Twinject Twinject 0.15 Twinject 0.3 Twinject 0.30 UNII-YKH834O4BH Vaponefrin Vasoconstrictine Vasoconstrictor Vasodrine Vasoton Vasotonin adrenaline bmse000316 d-Adrenaline epinephrine l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol l-Adrenalin l-Adrenaline l-Epinephine l-Epinephrine (synthetic) l-Epirenamine l-Methylaminoethanolcatechol levoepinephrine nchembio747-comp9 |
| | 3 | | Cosyntropin | approved | Phase 4 | 27 | 16960-16-0 | 16129617 | 16960-16-0 ATCH (1-24) Adrenocorticotropic hormone fragment 1-24 human, rat COSYNTROPIN Corticotropin tetracosapeptide Cortrosyn Cortrosyn (TN) Cosyntropin Cosyntropin (USAN) | D00284 Tetracosactide Tetracosactide (INN) Tetracosactrin adrenocorticotropic hormone 1-24 alpha(1-24)-corticotrophin beta(1-24)-corticotrophin corticotropin-(1-24) corticotropin-(1-24) tetracosapeptide α1-24-corticotrophin β1-24-corticotrophin |
| | 4 | | Cyclophosphamide | approved, investigational | Phase 4 | 2935 | 50-18-0, 6055-19-2 | 2907 | (+-)-Cyclophosphamide (-)-Cyclophosphamide (RS)-Cyclophosphamide 1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin 2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide 4-Hydroxy-cyclophosphan-mamophosphatide 50-18-0 60007-95-6 6055-19-2 (monohydrate) 75526-90-8 AC1L1EQQ AI3-26198 ASTA ASTA B518 Anhydrous cyclophosphamide Asta B 518 B 518 B-518 BRN 0011744 BSPBio_002099 Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester C 0768 C07888 C7H15Cl2N2O2P CB 4564 CB-4564 CCRIS 188 CHEBI:4027 CHEMBL32520 CHEMBL88 CID2907 CP CPA CTX CY Ciclofosfamida Ciclofosfamida [INN-Spanish] Ciclofosfamide Ciclophosphamide Ciclophosphamide [INN] Clafen Claphene Cycloblastin Cyclophosphamid Cyclophosphamide Cyclophosphamide (INN) Cyclophosphamide (TN) Cyclophosphamide (anhydrous form) Cyclophosphamide (anhydrous) Cyclophosphamide Monohydrate Cyclophosphamide Sterile Cyclophosphamide anhydrous Cyclophosphamide, (+-)-Isomer Cyclophosphamides Cyclophosphamidum Cyclophosphamidum [INN-Latin] Cyclophosphan Cyclophosphane Cyclophosphanum Cyclophosphoramide Cyclostin Cyklofosfamid Cyklofosfamid [Czech] Cytophosphan Cytophosphane Cytoxan Cytoxan (TN) Cytoxan Lyoph D,L-Cyclophosphamide D07760 | DB00531 DivK1c_000246 EINECS 200-015-4 EU-0100238 Endoxan Endoxan R Endoxan-Asta Endoxana Endoxanal Endoxane Enduxan Genoxal HMS2090A12 HSDB 3047 Hexadrin IDI1_000246 KBio1_000246 KBio2_001338 KBio2_003906 KBio2_006474 KBio3_001319 KBioGR_000888 KBioSS_001338 LS-1302 LS-99787 Ledoxina Lopac-C-0768 Lopac0_000238 Lyophilized Cytoxan Mitoxan MolPort-001-783-420 N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide NCGC00015209-01 NCGC00015209-03 NCGC00015209-06 NCGC00091741-02 NCGC00091741-03 NCI-C04900 NCI60_002097 NINDS_000246 NSC 26271 NSC-26271 NSC26271 NSC273033 NSC273034 Neosar Occupation, cyclophosphamide exposure Procytox RCRA waste no. U058 Rcra Waste Number U058 Rcra waste number U058 Revimmune S1217_Selleck SK 20501 SPBio_001071 STK177249 STOCK2S-91217 Semdoxan Sendoxan Senduxan Spectrum2_001146 Spectrum3_000370 Spectrum4_000304 Spectrum5_000795 Spectrum_000858 UNII-6UXW23996M WLN: T6MPOTJ BO BN2G2G Zyklophosphamid Zyklophosphamid [German] bis(2-Chloroethyl)phosphami de cyclic propanolamide bis(2-Chloroethyl)phosphamide cyclic propanolamide ester cyclophosphamide |
| | 5 | | Docosanol | approved, investigational | Phase 4 | 1 | 30303-65-2, 661-19-8 | 12620 | 1-DOCOSANOL 1-Docosanol 169102_ALDRICH 30303-65-2 4-01-00-01906 (Beilstein Handbook Reference) 43960_FLUKA 661-19-8 A3D72D45-625E-49B5-B0FC-394010B3485D AC-19852 AC1L1ZZI AC1Q2W4M AC1Q7CQ8 AI3-36489 Abreva Abreva (TN) BEHENYL ALCOHOL, 98% BRN 1770470 Behenic alcohol Behenyl alcohol Behenyl alcohol, AI3-36489, Behenic alcohol, 1-Docosanol, Docosyl alcohol, IK-2, Tadenan Behenyl alcohol, Abreva, 1-Docosanol, Docosanol C22H46O CCRIS 8943 CHEBI:31000 CHEMBL1200453 CID12620 CPD-7845 D03884 D0964 DB00632 Debat Doconsanol Docosan-1-ol Docosanol Docosanol (USAN) | Docosanol (VAN) Docosanol [USAN] Docosyl alcohol EINECS 211-546-6 Erazaban HMS2093P22 HSDB 5739 Healip Herepair IK 2 IK.2 InChI=1/C22H46O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23/h23H,2-22H2,1H LMFA05000008 LS-174295 LS-63381 Lanette 22 Lidakol Lidavol MolPort-003-666-887 N-Docosanol NAA 422 NCGC00159370-02 NCGC00159370-03 NSC 8407 NSC8407 Nacol 22-97 S1637_Selleck SBB060170 Stenol 1822 Stenol 1822A TL8004688 Tadenan UNII-9G1OE216XY V-1326 docosan-1-ol n-Docosanol | |
| | 6 | | Calcium carbonate | approved | Phase 4 | 215 | 471-34-1 | | CaCO3 Calcium carbonate Calcium carbonate (1:1) Calciumcarbonat Carbonate de calcium | Carbonato de calcio Carbonic acid calcium salt (1:1) E 170 Kalziumkarbonat Kohlensaurer kalk Precipitated calcium carbonate | |
| | 7 | | Miconazole | approved, investigational, vet_approved | Phase 4, Phase 2, Phase 1 | 3706 | 22916-47-8 | 4189 | (+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole 1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole 1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole 1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole 1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole 1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole 22832-87-7 (NITRATE) 22916-47-8 75319-47-0 AB00053500 AC1L1HM1 AKOS001574474 Aflorix(nitrate) Albistat(nitrate) Andergin(nitrate) BPBio1_000279 BRD-A82396632-001-03-0 BRD-A82396632-008-02-7 BRN 0965511 BSPBio_000253 BSPBio_002033 CCRIS 7924 CHEBI:6923 CHEMBL91 CID4189 CPD-4501 Conofite(nitrate) D00416 DB01110 Dactarin Daktarin IV Daktarin iv DivK1c_000156 EINECS 245-324-5 Epi-Monistat(nitrate) Femizol-M Florid(nitrate) Gyno-Daktar(nitrate) HMS1568M15 HMS2090B21 I14-14342 IDI1_000156 Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI) KBio1_000156 KBio2_001445 KBio2_004013 KBio2_006581 KBio3_001533 KBioGR_000581 KBioSS_001445 LS-78378 Lotrimin AF(nitrate) MCZ MJR 1762 MLS002222203 Micantin (nitrate) Miconasil Nitrate | Miconazol Miconazol [INN-Spanish] Miconazole Miconazole (JP15/USP/INN) Miconazole 3 Miconazole 3 Combination Pack Miconazole 7 Combination Pack Miconazole [USAN:BAN:INN:JAN] Miconazole nitrate salt Miconazole-7 Miconazolo Miconazolo [DCIT] Miconazolum Miconazolum [INN-Latin] Micozole Minostate MolPort-002-557-553 Monazole 7 Monista (nitrate) Monistat Monistat (TN) Monistat 1 Combination Pack Monistat 3 Dual-Pak Monistat 3 Vaginal Ovules Monistat 5 Tampon Monistat 7 Dual-Pak Monistat 7 Vaginal Suppositories Monistat Dual- PAK Monistat IV Monistat iv (TN) Monistat iv (tn) Monistat-Derm NCI60_001353 NCI60_001380 NINDS_000156 NSC 170986 NSC169434 NSC170986 Novo-Miconazole Vaginal Ovules Oprea1_091955 Prestwick0_000067 Prestwick1_000067 Prestwick2_000067 Prestwick3_000067 Prestwick_335 R 18134 R-14,889 SMR001307249 SPBio_000976 SPBio_002174 STK834405 STOCK1S-93556 Spectrum2_001048 Spectrum3_000507 Spectrum4_000061 Spectrum5_001297 Spectrum_000965 UNII-7NNO0D7S5M Vusion Zimycan imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI) miconazole | |
| | 8 | | Ephedrine | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 628 | 299-42-3 | 9294 | ( )-Pseudoephedrine (+)-Ephedrin (+)-Ephedrine (+)-Pseudoephedrine (+)-psi-Ephedrine (+)-threo-Ephedrine (+-)-Ephedrine (-)-Ephedrine (-)-Pseudoephedrine (-)-psi-Ephedrine (-)-threo-Ephedrine (1R,2R)-Ephedrine (1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane (1S,2R)-Ephedrine (L)-EPHEDRINE --EPHEDRINE 1-EPHEDRINE 1-Sedrin 134910_ALDRICH 287636_ALDRICH 287644_ALDRICH 299-42-3 304-87-0 30987-59-8 321-96-0 321-97-1 321-98-2 37577-31-4 38732-95-5 45261_FLUKA 4607-45-8 50-98-6 50906-05-3 53214-57-6 649031_ALDRICH 6912-63-6 7009-81-6 90-82-4 968-63-8 AC-20231 AC-20292 AC1L1JGK AC1L1NUA AC1L1RFA AC1L1SR1 AC1L1T31 AC1L1Y3M AC1O8JUO AC1Q3XJE AC1Q3XJM AC1Q3XJN AC1Q59F5 AC1Q7701 AI3-02761 AKOS000268842 AR-1A0126 AR-1I7143 Acunaso Acunaso (TN) Afrinol Ambap299-42-3 BIDD:GT0817 BRN 3197916 BRN 4231286 BSPBio_001946 BSPBio_001968 BSPBio_003261 Benylin Decongestant Besan Biophedrin C01575 C02765 C10H15NO CHEBI:15407 CHEBI:51209 CHEMBL1590 CHEMBL211456 CHEMBL357080 CID11972440 CID5032 CID62946 CID6710657 CID7028 CID8650 CID9294 CID9457 CPD-9954 CPDD 0049 Cenafed D00124 D08449 DB00852 DB01364 Decofed DivK1c_000181 DivK1c_000451 DivK1c_000461 Drixoral N.D. EINECS 202-017-0 EINECS 202-018-6 EINECS 206-080-5 EINECS 206-292-8 EINECS 206-293-3 Eciphin Efedrin Efidac/24 Eltor 120 Ephedral Ephedremal Ephedrin Ephedrine Ephedrine (TN) Ephedrine (USP) Ephedrine [USAN:BAN] Ephedrine l-form Ephedrital Ephedrol Ephedrosan Ephedrotal Ephedsol Ephendronal Ephoxamin Fedrin Genaphed HSDB 3072 HSDB 3177 I-Sedrin I01-3584 I01-8925 I01-8928 | IDI1_000181 IDI1_000451 IDI1_000461 Isoephedrine Jsp005664 KBio1_000181 KBio1_000451 KBio1_000461 KBio2_001358 KBio2_001500 KBio2_003926 KBio2_004068 KBio2_006494 KBio2_006636 KBio3_001188 KBio3_001446 KBio3_002762 KBioGR_001013 KBioGR_001763 KBioSS_001358 KBioSS_001500 KST-1A9168 Kratedyn L(+)-psi-Ephedrine L(-)-Ephedrine L-(+)-Ephedrine L-(-)-Ephedrine L-Ephedrine L-erythro-2-(Methylamino)-1-phenylpropan-1-ol L000968 LS-125921 LS-125922 LS-43083 LS-63961 LS-63962 LS-63963 LS-63964 Lexofedrin Lopac-E-3250 Lopac0_000501 MLS000069657 Manadrin Mandrin Maxenal MolPort-001-684-474 MolPort-001-684-477 MolPort-001-684-478 MolPort-001-684-479 MolPort-001-769-085 Myfedrine NCGC00015408-01 NCGC00015408-02 NCGC00162174-01 NCGC00178180-01 NCGC00178889-01 NCI-C55652 NCI60_002955 NINDS_000181 NINDS_000451 NINDS_000461 NSC 165609 NSC 170951 NSC 8971 NSC165609 NSC170951 NSC8971 Nasol Neodurasina Neodurasina (TN) Oprea1_287330 PDSP1_000168 PDSP1_001106 PDSP1_001343 PDSP1_001345 PDSP1_001346 PDSP1_001347 PDSP2_000167 PDSP2_001090 PDSP2_001327 PDSP2_001329 PDSP2_001330 PDSP2_001331 PSEUDOEPHEDRINE Pedia Care Pseudo Pseudo 60's Pseudo-12 Pseudoefedrina Pseudoephedrine (D) Pseudoephedrinum Psi-ephedrin Psi-ephedrine Robidrine SMR000059174 SPBio_000214 SPBio_001365 SPBio_001377 ST023802 STK367993 STOCK1N-42675 Sanedrine Spectrum2_000137 Spectrum2_001303 Spectrum2_001309 Spectrum3_000414 Spectrum3_000563 Spectrum3_001771 Spectrum4_000497 Spectrum4_001162 Spectrum5_000650 Spectrum5_000879 Spectrum5_001106 Spectrum_000878 Spectrum_001020 Sudafed Sudafed Decongestant UNII-03VRY66076 UNII-7CUC9DDI9F UNII-GN83C131XS Vencipon WLN: QYR & Y1 & M1 WLN: QYR&Y1&M1 Zephrol d-Ephedrine d-Isoephedrine d-Pseudoephedrine d-psi-Ephedrine l-Ephedrine l-Pseudoephedrine racephedrine trans-Ephedrine | |
| | 9 | | Hydrocortisone | approved, vet_approved | Phase 4, Phase 2, Phase 3, Phase 1 | 667 | 50-23-7 | 5754, 657311 | (11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione (11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione 11-Hydrocortisone 11-beta-Hydrocortisone 11-beta-Hydroxycortisone 11a-Hydroxycorticosterone 11alpha-Hydroxycorticosterone 11b,17,21-Trihydroxyprogesterone 11b-Hydrocortisone 11b-Hydroxycortisone 11beta,17,21-Trihydroxyprogesterone 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione 11beta-Hydrocortisone 11beta-Hydroxycortisone 11beta-hydrocortisone 11β-hydrocortisone 17-Hydroxycorticosterone 17a-Hydroxycorticosterone 17alpha-Hydroxycorticosterone 2v95 4-Pregnen-11beta,17alpha,21-triol-3,20-dione 4-Pregnene-11alpha,21-triol 3,20-dione 4-Pregnene-11b,17a,21-triol-3,20-dione 50-23-7 8056-08-4 80562-38-5 8063-42-1 AC-12902 AC1L1L2B ACETASOL HC ACETIC ACID W/ HYDROCORTISONE AI3-25006 AKOS001582651 Acticort Acticort (TN) Aeroseb HC Aeroseb-HC Ala-Cort Ala-Scalp Alacort Algicirtis Alphaderm Amberin Anflam Anti-inflammatory hormone Anucort Anucort-HC Anusol HC Anusol HC (TN) Aquacort Aquanil HC B48448A1-24BA-47CA-8D9E-43E5BC949386 BPBio1_000544 BRD-K93568044-001-03-1 BSPBio_000494 Balneol-hc Barseb HC Basan-Corti Beta-hc Bio-0648 C00735 C21H30O5 CCRIS 5854 CHEBI:17650 CHEMBL389621 CID5754 COR-OTICIN CPD000653523 CaldeCORT Spray Cetacort Chronocort Clear aid Cleiton Cobadex Colocort Colocort (TN) Compound F Compound F (kendall) Cor-Tar-Quin Corhydron Cort-Dome Cort-Quin Cortanal Cortef Cortef (TN) Cortenema Cortesal Corticreme Cortifair Cortifan Cortifoam Cortiment Cortisol Cortisol alcohol Cortisol, Hydrocortisone Cortisolonum Cortisporin Cortisporin Otico Cortispray Cortizol Cortolotion Cortonema Cortoxide Cortril Cremesone Cremicort-H Cutisol Cyclodextrin-encapsulated hydrocortisone D00088 DB00741 DB07886 Delacort Derm-Aid Dermacort Dermaspray Dermil Dermocortal Dermolate Dihydrocostisone Dioderm Dome-cort Domolene-HC Drotic DuoCort EINECS 200-020-1 EU-0100594 Ef corlin Efcorbin Efcortelan Efcortelin Eldecort Eldercort Epicort Epicortisol Epiderm H Esiderm H Evacort Ficortril Fiocortril Flexicort Foille Insetti Genacort Genacort (lotion) Glycort Gyno-Cortisone H 4001 H-Cort H0135_SIGMA H0396_SIGMA H0888_SIGMA H3160_SIGMA H4001_SIGMA H6909_SIGMA HC HC #1 | HC #4 HC (HYDROCORTISONE) HMS1569I16 HMS2090M04 HSDB 3339 HYDROCORTISONE AND ACETIC ACID HYDROCORTISONE IN ABSORBASE Heb Cort Heb-Cort Hi-cor Hidalone Hidro-Colisona Hidrocortisona Hidrocortisona [INN-Spanish] Hycort Hycortol Hycortole Hydracort Hydrasson Hydro-Adreson Hydro-Colisona Hydro-RX Hydro-colisona Hydrocort Hydrocortal Hydrocorticosterone Hydrocortisone Hydrocortisone (JP15/USP/INN) Hydrocortisone Acetate Hydrocortisone Base Hydrocortisone Butyrate Hydrocortisone Sodium Phosphate Hydrocortisone Valerate Hydrocortisone [INN:BAN:JAN] Hydrocortisone alcohol Hydrocortisone base Hydrocortisone free alcohol Hydrocortisone solution Hydrocortisone-Water Soluble Hydrocortisonum Hydrocortisonum [INN-Latin] Hydrocortistab Hydrocortisyl Hydrocortone Hydroskin Hydroxycortisone Hysone Hytisone Hytone Hytone (TN) Hytone lotion Idrocortisone Idrocortisone [DCIT] Incortin-H Incortin-hydrogen Kendall'S compound F Kendall's compound F Komed HC Kyypakkaus LMST02030001 LS-7439 Lacticare HC Lacticare-HC Lactisona Lopac0_000594 Lubricort MLS000069609 MLS001148103 MLS002207135 MLS002222189 Maintasone Medicort Meusicort Mildison Milliderm MolPort-001-794-637 NCGC00022848-06 NCGC00022848-07 NCGC00022848-09 NCGC00022848-12 NCI60_000118 NSC 10483 NSC-10483 NSC10483 Neo-Cort-Dome Neo-Cortef Neosporin-H Ear Nogenic HC Nutracort Nystaform-HC ORLEX HC Optef Otalgine Otic-Neo-Cort-Dome Otobiotic Otocort Otosone-F Pediotic Suspension Penecort Permicort Polcort H Preparation H Hydrocortisone Cream Prepcort Prestwick0_000447 Prestwick1_000447 Prestwick2_000447 Prestwick3_000447 Prestwick_265 Prevex HC Proctocort Proctofoam Proctozone HC Protocort Racet Rectasol-HC Rectoid Reichstein'S substance M Reichstein's substance M Remederm HC S1696_Selleck SAM002264617 SMP1_000156 SMR000059022 SMR000653523 SPBio_002433 Sanatison Scalp-Cort Scalpicin Capilar Schericur Scheroson F Sigmacort Signef Stie-cort Stiefcorcil Synacort Systral Hydrocort Tarcortin Texacort Texacort lotion 25 Timocort Topicort Transderma H Traumaide UNII-WI4X0X7BPJ UPCMLD-DP133 UPCMLD-DP133:001 Uniderm Vioform-Hydrocortisone VoSol HC Vytone Zenoxone [3H]cortisol component of Lubricort component of Neo-Cort-Dome component of Otalgine hydrocortisone | |
| | 10 | | Prednisone | approved, vet_approved | Phase 4, Phase 2, Phase 3 | 1398 | 53-03-2 | 5865 | (1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione (8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione (8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione .delta. E .delta.(sup1)-Cortisone .delta.-Cortelan .delta.-Cortisone .delta.-Cortone .delta.-E .delta.1-Cortisone .delta.1-Dehydrocortisone .delta.sone 1,2-Dehydrocortisone 1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione 1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione 1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione 1-Cortisone 1-Dehydrocortisone 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione 17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione 53-03-2 68-59-7 81552_FLUKA AC-11112 AC1L1LB2 AC1Q29EZ ACon0_000082 ACon1_000297 AI3-52939 Adasone Ancortone Apo-Prednisone Apo-prednisone BPBio1_000323 BRD-K85883481-001-04-2 BSPBio_000293 Betapar Bicortone Bio-0649 C07370 C21H26O5 CCRIS 2646 CHEBI:8382 CHEMBL635 CID5865 CPD001227202 Cartancyl Colisone Cortan Cortancyl Cortidelt Cotone DB00635 Dacorten Dacortin Decortancyl Decortin Decortisyl Dehydrocortisone Dekortin Delcortin Dellacort Dellacort A Delta Cortelan Delta E Delta E. Delta-Cortelan Delta-Dome Delta-cortelan Delta-cortisone Delta-cortone Delta-dome Deltacortene Deltacortisone Deltacortone Deltasone Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone Deltison Deltisona Deltisone Deltra Di-Adreson Diadreson EINECS 200-160-3 Econosone Encorton Encortone Enkortolon Enkorton Fernisone Fiasone HMS1568O15 HMS2090J13 HSDB 3168 Hostacortin In-Sone Incocortyl | Juvason Kortancyl LMST02030180 LS-1325 Liquid Pred Lisacort Lodotra MEGxm0_000443 MLS001061265 MLS001304073 MLS001335907 MLS001335908 MLS002154191 MLS002207083 Me-Korti Metacortandracin Meticorten Meticorten (Veterinary) Metrevet (Veterinary) MolPort-001-740-041 NCGC00090766-01 NCGC00090766-02 NCGC00090766-03 NCI-C04897 NCI60_000008 NSC 10023 NSC10023 Nisona Nizon Novoprednisone Nurison Orasone Origen Prednisone P1276 P6254_SIGMA PRD Panafcort Panasol Paracort Parmenison Pehacort Precort Predeltin Prednicen-M Prednicorm Prednicort Prednicot Prednidib Prednilonga Prednison Prednisona Prednisona [INN-Spanish] Prednisone Prednisone Intensol Prednisone [INN:BAN] Prednisonum Prednisonum [INN-Latin] Prednitone Prednizon Prednovister Presone Prestwick0_000077 Prestwick1_000077 Prestwick2_000077 Prestwick3_000077 Prestwick_405 Pronison Pronisone Rectodelt Retrocortine S1622_Selleck SAM002264641 SK-Prednisone SMR000718760 SMR001227202 SPBio_002214 Servisone Sone Sterapred Supercortil U 6020 UNII-VB0R961HZT Ultracorten Ultracortene WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ Winpred Wojtab ZINC03875357 Zenadrid Zenadrid (veterinary) Zenadrid [veterinary] delta cortelan delta(sup 1)-Cortisone delta(sup 1)-Dehydrocortisone delta-1-Cortisone delta-1-Dehydrocortisone delta-Cortisone delta-Cortone | |
| | 11 | | Pseudoephedrine | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 628 | 90-82-4 | 7028 | ( )-Pseudoephedrine (+) threo-2-(methylamino)-1-phenyl-1-propanol (+)-(1S,2S)-Pseudoephedrine (+)-Pseudoephedrine (+)-psi-Ephedrine (+)-threo-Ephedrine (1S,2S)-(+)-Pseudoephedrine (1S,2S)-2-(methylamino)-1-phenylpropan-1-ol (1S,2S)-2-Methylamino-1-phenyl-1-propanol (1S,2S)-Pseudoephedrine (1S,2S)-Pseudoephedrine, polymer-bound 1-Ephedrine 2-(Methylamino)-1-phenyl-1-propanol 287636_ALDRICH 304-87-0 30987-59-8 37577-31-4 649031_ALDRICH 90-82-4 AC-20292 AC1L1NUA Acunaso Acunaso (TN) Afrinol BIDD:GT0817 BRD-K84175871-003-02-2 BSPBio_003261 Balminil Decongestant Syrup Benylin Decongestant Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alpha-S)- (9CI) Besan C02765 C10H15NO CHEBI:51209 CHEMBL1590 CID7028 CPD-9954 Cenafed D-Isoephedrine D-Pseudoephedrine D-Pseudoephedrine base D-Psi-2-Methylamino-1-phenyl-1-propanol D-Psi-Ephedrine D08449 DB00852 Decofed Dimetapp Decongestant Dimetapp Decongestant Pediatric Drops DivK1c_000451 Drixoral N.D. Drixoral Nasal Decongestant EINECS 202-018-6 Efidac 24 Pseudoephedrine Hcl Efidac/24 Eltor 120 Ephedrine Genaphed HSDB 3177 I01-8928 IDI1_000451 Isoephedrine KBio1_000451 | KBio2_001358 KBio2_003926 KBio2_006494 KBio3_002762 KBioGR_001763 KBioSS_001358 L(+)-Psi-Ephedrine L(+)-psi-Ephedrine L-(+)-Pseudoephedrine LS-125922 Lopac-E-3250 Maxenal MolPort-001-684-474 Myfedrine NCGC00015408-01 NCGC00178180-01 NCI60_002955 NINDS_000451 Neodurasina Neodurasina (TN) Novafed PDSP1_001347 PSEUDOEPHEDRINE Pedia Care Pseudo Pseudo 60's Pseudo-12 Pseudoefedrina Pseudoefedrina [INN-Spanish] Pseudoephedrine Pseudoephedrine (D) Pseudoephedrine (INN) Pseudoephedrine D-form Pseudoephedrine Ephedrine Pseudoephedrine [INN:BAN] Pseudoephedrine d-form Pseudoephedrinum Pseudoephedrinum [INN-Latin] Psi-ephedrin Psi-ephedrine Robidrine SPBio_001365 STOCK1N-42675 Spectrum2_001303 Spectrum3_001771 Spectrum4_001162 Spectrum5_000650 Spectrum_000878 Sudafed Sudafed Decongestant Sudafed Decongestant 12 Hour Sudafed Decongestant Extra Strength Triaminic AM Decongestant Formula Triaminic Infant Oral Decongestant Drops UNII-7CUC9DDI9F alpha-(1-(Methylamino)ethyl)benzyl alcohol d-Isoephedrine d-Pseudoephedrine d-psi-2-Methylamino-1-phenyl-1-propanol d-psi-Ephedrine pseudoéphédrine trans-Ephedrine ψ-ephedrine | |
| | 12 | | Cevimeline | approved | Phase 4 | 5 | 107233-08-9 | 83898, 25137844 | (+-)-cis-2-Methylspiro(1,3-oxathiolane-5,3'-quinuclidine) hydrochloride, hemihydrate (+/-)cis-2-methylspiro(1-azabicyclo[2.2.2]octance-3,5'-(1,3)oxathiolane) hydrochloride hemihydrate (2R,2'R)-2'-methylspiro[4-azabicyclo[2.2.2]octane-2,5'-[1,3]oxathiolane] dihydrochloride hydrate (2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane] (2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane] dihydrate hydrochloride (2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane] hydrate dihydrochloride (2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane] hydrate hydrochloride 107233-08-9 153504-70-2 2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine AC1L36EF AC1L36GD AC1NR4MS AC1OCEXD AF 102B AF-102B AF102B BIDD:GT0265 C10H17NOS CHEMBL1200362 CID5284532 CID6918023 CID83898 CID83927 Cevimelina Cevimeline Cevimeline (INN) Cevimeline HCl 1/2H2O Cevimeline [INN] | Cevimeline hydrochloride Cevimeline hydrochloride (USAN) Cevimeline hydrochloride [USAN] Cevimeline hydrochloride hemihydrate Cevimeline hydrochloride hydrate Cevimeline hydrochloride hydrate (JAN) Cevimeline.HCl Cevimelinum D00661 D07667 DB00185 Evoxac Evoxac (TN) FKS-508 Fks 508 HSDB 7286 LS-145782 LS-172037 NCGC00181793-01 SND 5008, AF-102B, FKS-508 SND-5008 SNI-2011 SNK-508 Saligren Saligren (TN) Sni 2011 UNII-K9V0CDQ56E UNII-P81Q6V85NP cevimeline hydrochloride hydrate cis-2-Methylspiro(1,3-oxathiolane-5,3')quinuclidine hydrochloride hydrate (2:2:1) | |
| | 13 | | Tacrolimus | approved, investigational | Phase 4 | 1102 | 104987-11-3 | 445643, 439492 | (-)-FK 506 (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone 104987-11-3 109581-93-3 (Hydrate) 15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone, 3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN AC-1182 AC1L1K7H AC1L97GB AC1L9IBU AKOS005145901 Advagraf Ambap104987-11-3 Ambap5429 Anhydrous tacrolimus BCBcMAP01_000194 BRD-K35452788-001-02-1 BSPBio-001279 BSPBio_001279 Bio-0921 Bio2_000470 Bio2_000950 C01375 C44H69NO10 CCRIS 7124 CHEBI:100924 CHEBI:61049 CHEMBL1200738 CID11158639 CID11556866 CID439492 CID445643 CID5372 CID5472317 CID6426916 CID6436007 CID6473866 CID6536850 CID6610362 CID6912836 CID9832283 CID9853905 CID9918805 CID9940643 CID9963169 CPD-10016 CPD000466356 D08556 DB00864 DivK1c_001040 FK 506 FK-506 FK5 FK506 FR 900506 FR-900506 | FR900506 FT-0082660 Fk-506 Fujimycin Graceptor HMS1362O21 HMS1792O21 HMS1990O21 HMS2051C18 HMS2093M19 HMS503O21 IDI1_001040 IDI1_002225 K506 KBio1_001040 KBio2_000619 KBio2_003187 KBio2_005755 KBio3_001097 KBio3_001098 KBioGR_000619 KBioSS_000619 L 679934 L-679934 LCP-Tacro LMPK04000003 LS-64247 MLS000759471 MLS001424054 Modigraf MolPort-003-666-518 NCGC00163470-01 NCGC00163470-02 NCGC00163470-03 NCGC00163470-04 NCGC00179232-01 NChemBio.2007.16-comp1 NINDS_001040 NSC717865 Prograf Prograf (TN) Protopic Protopy S5003_Selleck SAM001246677 SMR000466356 Tacarolimus Tacrolimus (INN) Tacrolimus (Prograf?) Tacrolimus (anhydrous) Tacrolimus anhydrous Tacrolimus hydrate Tacrolimus, anhydrous Tsukubaenolide UNII-Y5L2157C4J nchembio.2007.23-comp2 tacrolimus tacrolimus hydrate | |
| | 14 | | Oxybutynin | approved, investigational | Phase 4, Phase 2 | 68 | 5633-20-5 | 4634 | 1508-65-2 (hydrochloride) 4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester 4-(diethylamino)-2-butynyl-alpha-cyclohexyl-alpha-hydroxybenzeneacetate 4-(diethylamino)-2-butynyl-alpha-phenylcyclohexaneglycolate 4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate 4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate 4-Diethylamino-2-butinyl alpha-cyclohexylmandelat 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate 5633-20-5 AC-2153 AC1L1ILV BPBio1_000214 BRD-A65013509-003-03-8 BSPBio_000194 Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester C07360 CCRIS 1923 CHEBI:7856 CHEMBL1231 CID4634 Cyclohexaneglycolic acid, .alpha.-phenyl-, 4-(diethylamino)-2-butynyl ester Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester Cystrin D00465 DB01062 Ditropan Ditropan, Lyrinel XL, Oxytrol, Oxybutynin FT-0082890 HSDB 3270 I06-2117 L000923 LS-28714 | Lopac0_000923 MolPort-003-849-741 NCGC00015767-06 NCGC00089795-02 Oxibutinina Oxibutinina [INN-Spanish] Oxibutyninum Oxybutinin Oxybutynin Oxybutynin (USAN/INN) Oxybutynin Base Oxybutynin Chloride Oxybutynin Hydrochloride Oxybutynin [USAN:INN:BAN] Oxybutynin topical gel Oxybutynine Oxybutynine [INN-French] Oxybutyninum Oxybutyninum [INN-Latin] Oxytrol Oxytrol (TN) Pollakisu Prestwick0_000287 Prestwick1_000287 Prestwick2_000287 Prestwick3_000287 S1754_Selleck SPBio_002413 Transdermal patch UNII-K9P6MC7092 oxybutynin oxybutynin topical gel transdermal patch | |
| | 15 | | Dexamethasone | approved, investigational, vet_approved | Phase 4, Phase 3, Phase 2 | 2171 | 50-02-2 | 5743 | (3H)-Dexamethasone .delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol .gamma.corten 1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone 1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone 1-Dehydro-16α-methyl-9α-fluorohydrocortisone 137098-19-2 16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol 16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone 16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone 16-alpha-Methyl-9-alpha-fluoroprednisolone 16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol 16alpha -Methyl-9alpha -fluoroprednisolone 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol 16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone 16alpha-Methyl-9alpha-fluoroprednisolone 16α-Methyl-9α-fluoro-1-dehydrocortisol 23495-06-9 31375_FLUKA 46165_FLUKA 46165_RIEDEL 50-02-2 8054-59-9 9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione 9-Fluoro-16-methylprednisolone 9-alpha-Fluoro-16-alpha-methylprednisolone 9.alpha.-Fluoro-16.alpha.-methylprednisolone 906422-84-2 9A-FLUORO-16BETA-METHYLPREDNISOLONE 9alpha -Fluoro-16alpha -methylprednisolone 9alpha-Fluoro-16alpha-methylprednisolone 9alpha-fluoro-16alpha-methyl-Prednisolone 9α-Fluoro-16α-methylprednisolone AC-11056 AC1L1L1H AC1Q29DM AI3-50934 Adexone Aeroseb-D Aeroseb-Dex Aeroseb-dex Ak Dex Oph Otic Soln 0.1% Alcon Brand of Dexamethasone Anaflogistico Aphtasolon Aphthasolone Apo-dexamethasone Auxiron Azimycin (veterinary) Azium Azium (Veterinary) Azium (veterinary) BIDD:ER0494 BIDD:PXR0060 BRD-K38775274-001-02-3 BRD-K38775274-001-06-4 BSPBio_000995 Bisu DS Bisu Ds C15643 C22H29FO5 CCRIS 7067 CHEBI:41879 CHEMBL384467 CID5743 CPD-10549 CPD001227192 Calonat Corson Corsone Cortisumman D00292 D003907 D1756_SIGMA D4902_SIGMA D6645_SIGMA D8893_SIGMA D9184_SIGMA DB01234 DEX DEXA DEXONE 0.5 DEXONE 0.75 DEXONE 1.5 DEXONE 4 DXM DXMS Decacort Decacortin Decaderm Decadron Decadron (TN) Decadron Tablets, Elixir Decadron, Dexamethasone Decadron-LA Decadron-La Decagel Decaject Decaject L.A. Decaject-L.A. Decalix Decameth Decasone Decaspray Dectancyl Dekacort Delta1-9alpha-Fluoro-16alpha-methylcortisol Deltafluorene Dergramin Deronil Desadrene Desametasone Desametasone [DCIT] Desametasone [Dcit] Desamethasone Desameton Deseronil Dex-Ide Dex-ide Dexa Dexa Mamallet Dexa mamallet Dexa-Cortidelt Dexa-Cortisyl Dexa-Mamallet Dexa-Scheroson Dexa-Sine Dexa-cortidelt Dexa-cortisyl Dexa-scheroson Dexa-sine Dexacen-4 Dexacidin Dexacort Dexacortal Dexacortin Dexadeltone Dexafarma Dexair Dexalona Dexaltin Dexametasona Dexametasona [INN-Spanish] Dexametasone | Dexameth Dexamethansone Dexamethasone Dexamethasone (JP15/USP/INN) Dexamethasone Acetate Dexamethasone Alcohol Dexamethasone Base Dexamethasone Intensol Dexamethasone Sodium Phosphate Dexamethasone [INN:BAN:JAN] Dexamethasone alcohol Dexamethasone base Dexamethasone intensol Dexamethasone-omega Dexamethasonum Dexamethasonum [INN-Latin] Dexamethazone Dexamonozon Dexapolcort Dexapos Dexaprol Dexason Dexasone Dexasone 0.5mg Dexasone 0.75mg Dexasone 4mg Dexasporin Dexinolon Dexinoral Dexone Dexone 0.5 Dexone 0.75 Dexone 1.5 Dexone 4 Dexonium Dexpak Dextelan Dezone Dinormon Dxms ECR Brand of Dexamethasone EINECS 200-003-9 FT-0080377 Fluormethylprednisolone Fluormone Fluorocort Fortecortin Foy Brand of Dexamethasone Gammacorten HL-dex HMS1792A17 HMS1990A17 HMS2089N13 HSDB 3053 Hexadecadrol Hexadrol Hexadrol Elixir Hexadrol Tablets Hexadrol elixir Hl-Dex Hl-dex I06-1196 ICN Brand of Dexamethasone IontoDex Isopto-Dex Isopto-dex LS-7300 Lokalison F Lokalison f Loverine Luxazone MK 125 MLS001055412 MLS001332507 MLS001332508 Maxidex Maxidex Ont 0.1% Maxidex Sus 0.1% Maxitrol Mediamethasone Merck Brand of Dexamethasone Merz Brand 1 of Dexamethasone Merz Brand 2 of Dexamethasone Methylfluorprednisolone Mexidex Millicorten MolMap_000018 MolPort-003-846-433 Mymethasone NCGC00091019-01 NCGC00091019-02 NCGC00091019-03 NCGC00091019-04 NCGC00091019-05 NCI60_003067 NSC 34521 NSC34521 Naquasone (veterinary) Neomycin and polymyxin b sulfates and dexamethasone Neomycin and polymyxin b sulphates and dexamethasone OTO-104 Ocu-Trol Ocu-trol Oradexon PHL-dexamethasone PMS-dexamethasone Pet Derm III Pet Derm Iii Pet derm III Pet-Derm Iii Pms Dexamethasone Elixir 0.5mg/5ml Policort Posurdex Prednisolon F Prednisolon f Prednisolone F Prednisolone f Prodex S1322_Selleck SAM002548948 SGCUT00126 SK-Dexamethasone SK-dexamethasone SMP1_000092 SMR000857119 SMR001227192 ST50307091 Sandoz dexamethasone Sk-Dexamethasone Spectrum5_002019 Spoloven Sunia Sol D Sunia sol D Superprednol TL8003317 Tobradex Tobramycin and dexamethasone Tresaderm (veterinary) Turbinaire UNII-7S5I7G3JQL Visumetazone WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1 ZINC03875332 alpha -Fluoro-16-alpha -methylcortisol delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol delta1-9alpha-Fluoro-16alpha-methylcortisol dexamethasone nchembio809-comp2 to_000038 |
| | 16 | | Pilocarpine | approved | Phase 4, Phase 3, Phase 2 | 27 | 54-71-7, 92-13-7 | 5910 | (+)-Pilocarpine (3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone (3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one (3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one (3S,4R)-3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone (3S-cis)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone (3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone (3S-cis)-3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone 3-Ethyl-4-(3-methyl-3H-imidazol-4-ylmethyl)dihydrofuran-2-one 3-Ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydro-2(3H)-furanone 3-Ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one 3-ethyl-4-((1-methyl-1H-imidazol-5-yl)methyl)dihydro-2(3H)-furanone 3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one 54-71-7 91484-73-0 92-13-7 AC1L1J0W AC1L1LEF AC1Q6MOP AI3-50523 AR-1F3128 Adsorbocarpine Almocarpine Amistura P BIDD:GT0217 BPBio1_000548 BRD-K85090592-008-05-2 BSPBio_000498 BSPBio_002191 C07474 CHEBI:39460 CHEBI:8207 CHEMBL550 CID4819 CID5910 D00525 DB01085 DivK1c_000358 EINECS 202-128-4 Epicar HMS2089K17 HSDB 3163 IDI1_000358 Imidazole-5-butyric acid, alpha-ethyl-beta-(hydroxymethyl)-1-methyl-, gamma-lactone Isopto carpine Isoptocarpine KBio1_000358 KBio2_001587 KBio2_004155 KBio2_006723 KBio3_001691 KBioGR_000956 KBioSS_001587 L001181 LS-187208 LS-7661 Lopac0_000950 Lopac0_000960 Mi-Pilo Minims Pilocarpine Miocarpine MolPort-002-512-506 NCGC00023339-03 | NCGC00023339-06 NCGC00023339-07 NCGC00023339-08 NCGC00023339-09 NCGC00023339-12 NCGC00023339-13 NCI60_004403 NINDS_000358 NSC5746 Ocu-Carpine Ocusert Ocusert P 20 Ocusert Pilo-40 Ocusert pilo Ocusert pilo-20 Ocusert pilo-20 (TN) P.V. Carpine Liquifilm Pilagan Pilocarpin Pilocarpine Pilocarpine (JAN/USP) Pilocarpine HCl Pilocarpine Mononitrate, (3S-cis)-Isomer Pilocarpine [USAN:BAN:JAN] Pilocarpine chloride Pilocarpine hydrochloride Pilocarpine monohydrochloride Pilocarpine muriate Pilocarpine nitrate Pilocarpine, Monohydrochloride, (3S-cis)-Isomer Pilocarpol Pilokarpin Pilokarpin monohydrochloride Pilokarpol Piloptic-1 Piloptic-1/2 Piloptic-2 Piloptic-3 Piloptic-4 Piloptic-6 Pilostat Prestwick0_000449 Prestwick1_000449 Prestwick2_000449 Prestwick3_000449 SDCCGMLS-0003164.P005 SPBio_001287 SPBio_002437 STOCK1N-18408 Salagen Spectrum2_001284 Spectrum3_000546 Spectrum4_000478 Spectrum5_001379 Spectrum_001107 Spersacarpine Spersacarpine hydrochloride Syncarpine Tocris-0694 UNII-01MI4Q9DI3 ZINC00075008 beta-Pilocarpine hydrochloride isopilocarpine nchembio.78-comp9 pilocarpine |
| | 17 | | Glycerol | experimental, approved | Phase 4, Phase 2 | 238 | 56-81-5 | 753 | 1,2,3-Trihydroxypropane 1,2,3-propanetriol 1,2,3-trihydroxypropane Bulbold Cristal E 422 Emery 916 Glyceol Opthalgan Glycerin Glycerin, anhydrous Glycerin,anhydrous Glycerine Glycerinum | Glyceritol Glycerol Glycyl alcohol Glyrol Glysanin IFP Incorporation factor Mackstat H 66 Monoctanoin component D Osmoglyn Pricerine 9091 Propanetriol RG-S Trihydroxypropane Tryhydroxypropane |
| | 18 | | Dehydroepiandrosterone | approved, nutraceutical | Phase 4, Phase 2 | 95 | 53-43-0 | 9860744 | (+)-Dehydroisoandrosterone (3-beta)-3-Hydroxyandrost-5-en-17-one (3beta)-3-hydroxy-Androst-5-en-17-one (3beta,16alpha)-3,16-dihydroxy-androst-5-en-17-one 17-Chetovis 17-Hormoforin 3-beta-Hydroxy-5-androsten-17-one 3-beta-Hydroxyandrost-5-en-17-one 3b-Hydroxy-D5-androsten-17-one 3b-Hydroxyandrost-5-en-17-one 3beta-Hydroxy-D5-androsten-17-one 3beta-Hydroxyandrost-5-en-17-one 3beta-hydroxy-5-androsten-17-one 3beta-hydroxy-Androst-5-en-17-one 3beta-hydroxyandrost-5-en-17-one 3β-hydroxyandrost-5-en-17-one 5,6-Dehydroisoandrosterone 5,6-Didehydroisoandrosterone 5-Androsten-3-beta-ol-17-one 5-Androsten-3b-ol-17-one 5-Androsten-3beta-ol-17-one 5-DHEA 5-Dehydro-Epiandrosterone | 5-Dehydroepiandrosterone 5-dehydroepiandrosterone Andrestenol Androst-5-ene-3b-ol-17-one Androst-5-ene-3beta-ol-17-one Androsten-3beta-ol-17-one Androstenolone Astenile D5-Androsten-3b-ol-17-one D5-Androsten-3beta-ol-17-one DHEA Deandros Dehydro-epi-androsterone Dehydroandrosterone Dehydroepiandrosterone Dehydroisoandrosterone Diandron Diandrone Hydroxyandrostenone Prasterona Prasterone Prasteronum Prestara Psicosterone trans-Dehydroandrosterone |
| | 19 | | Ginseng | approved, nutraceutical | Phase 4 | 96 | 50647-08-0 | | Aralia ginseng root Asian ginseng Asian ginseng root Chinese ginseng root Ginseng (panax ginseng) Ginseng extract Ginseng, asian Hong shen root Insam root Korean ginseng | Korean ginseng root Ninjin root Panax ginseng Panax ginseng root Panax ginseng root extract Panax schinseng root Panax verus root Red ginseng Ren seng root Ren shen Ren shen root True ginseng root |
| | 20 | | Butyric Acid | experimental | Phase 4, Phase 1, Phase 2 | 380 | 107-92-6 | 264 | 1-Butanoate 1-Butanoic acid 1-Butyrate 1-Butyric acid 1-Propanecarboxylate 1-Propanecarboxylic acid 1-propanecarboxylic acid Butanate Butanic acid Butanoate Butanoic acid Buttersaeure Butyrate Butyric acid | Butyricum acidum Ethylacetate Ethylacetic acid Honey robber Kyselina maselna N-Butanoate N-Butanoic acid N-Butyrate N-Butyric acid N-butanoic acid N-butyric acid Propanecarboxylate Propanecarboxylic acid Propylformate Propylformic acid | |
| | 21 | | Autonomic Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 10150 | | | | 22 | | Cholinergic Agents | | Phase 4, Phase 2, Phase 3, Phase 1 | 3992 | | | | 23 | | Pharmaceutical Solutions | | Phase 4, Phase 3, Phase 2, Phase 1 | 8192 | | | | 24 | | Tetrahydrozoline | | Phase 4, Phase 3, Phase 2, Phase 1 | 621 | | | | 25 | | Vasoconstrictor Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 2122 | | | | 26 | | HIV Protease Inhibitors | | Phase 4, Phase 3, Phase 2 | 5470 | | | | 27 | | protease inhibitors | | Phase 4, Phase 3, Phase 2 | 5471 | | | | | 28 | | Respiratory System Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 4997 | | | | 29 | | Hydrocortisone acetate | | Phase 4, Phase 2, Phase 3, Phase 1 | 667 | | | | 30 | | Peripheral Nervous System Agents | | Phase 4, Phase 2, Phase 3, Phase 1 | 23689 | | | | 31 | | Nasal Decongestants | | Phase 4, Phase 3, Phase 2, Phase 1 | 598 | | | | 32 | | Adjuvants, Immunologic | | Phase 4, Phase 3, Phase 2, Phase 1 | 2554 | | | | 33 | | Ophthalmic Solutions | | Phase 4, Phase 3, Phase 2, Phase 1 | 1140 | | | | 34 | | Neurotransmitter Agents | | Phase 4, Phase 2, Phase 3, Phase 1 | 18340 | | | | 35 | | Racepinephrine | | Phase 4, Phase 2, Phase 3, Phase 1 | 985 | | | | 36 | | Antineoplastic Agents, Hormonal | | Phase 4, Phase 3, Phase 2 | 5592 | | | | 37 | | Antirheumatic Agents | | Phase 4, Phase 2, Phase 3, Phase 1 | 10956 | | | | 38 | | Anti-Ulcer Agents | | Phase 4, Phase 2 | 1842 | | | | 39 | | Calcineurin Inhibitors | | Phase 4, Phase 2 | 1622 | | | | 40 | | Hydrocortisone 17-butyrate 21-propionate | | Phase 4, Phase 2, Phase 3, Phase 1 | 667 | | | | 41 | | Anti-Inflammatory Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 10729 | | | | 42 | | Antifungal Agents | | Phase 4, Phase 2, Phase 1 | 3696 | | | | 43 | | Antacids | | Phase 4, Phase 2 | 1842 | | | | 44 | | Vaccines | | Phase 4, Phase 3, Phase 2, Phase 1 | 6611 | | | | 45 | | Anti-Infective Agents | | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 22062 | | | | 46 | | Dermatologic Agents | | Phase 4, Phase 2 | 5806 | | | | 47 | | Calcium, Dietary | | Phase 4 | 5713 | | | | 48 | | Acyclovir | | Phase 4 | 183 | | | | 49 | | Immunosuppressive Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 13086 | | | | 50 | | Antiviral Agents | | Phase 4, Phase 2, Phase 1 | 9967 | | |
Interventional clinical trials: (show top 50)
(show all 487)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue | Unknown status | NCT00543166 | Phase 4 | | 2 | Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases | Unknown status | NCT01151644 | Phase 4 | | 3 | Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome | Unknown status | NCT02370550 | Phase 4 | | 4 | Comparison of Topical Antiviral Agents for Labial Cold Sores (Herpes Labialis) | Unknown status | NCT00467662 | Phase 4 | | 5 | Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test | Unknown status | NCT00851942 | Phase 4 | | 6 | Effects of Mucoprotective Product on Xerostomia | Completed | NCT01316393 | Phase 4 | | 7 | Effect of Korean Red Ginseng (KRG) on Dry Mouth | Completed | NCT00911768 | Phase 4 | | 8 | Study of the Effectiveness of Cevimeline on Oral Health in Patients With Radiation Induced Xerostomia | Completed | NCT00466388 | Phase 4 | | 9 | Evaluation of an Electro-stimulator for the Treatment of Xerostomia | Completed | NCT00509808 | Phase 4 | | 10 | Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops | Completed | NCT01850979 | Phase 4 | | 11 | A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study | Completed | NCT02049112 | Phase 4 | | 12 | Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease | Completed | NCT02004067 | Phase 4 | | 13 | Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases | Completed | NCT00126997 | Phase 4 | | 14 | A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment | Completed | NCT00438048 | Phase 4 | | 15 | Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine | Completed | NCT00313950 | Phase 4 | | 16 | Assessment of Inflammatory Biomarkers Expressed in a Sjogren's Population: Effect of a Topical Steroid Intervention | Completed | NCT00631358 | Phase 4 | | 17 | Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations | Completed | NCT01777529 | Phase 4 | | 18 | Measles, Mumps, and Rubella (MMR) Immunity in College Students | Completed | NCT00962819 | Phase 4 | | 19 | Effect of Pilocarpine in Patients With Xerostomia | Recruiting | NCT02982577 | Phase 4 | | 20 | Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella Vaccine | Recruiting | NCT02880865 | Phase 4 | | 21 | A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients | Recruiting | NCT02948699 | Phase 4 | | 22 | Stereotactic Body Radiotherapy for Head and Neck Tumors | Active, not recruiting | NCT01344356 | Phase 4 | | 23 | Modified-release Compared to Conventional Hydrocortisone on Diurnal Fatigue in Secondary Hypoadrenalism | Enrolling by invitation | NCT02282150 | Phase 4 | | 24 | Use of Biotene Moisturizing Mouth Spray for Xerostomia Associated With Oral Oxybutynin Use | Not yet recruiting | NCT02522936 | Phase 4 | | 25 | Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia | Unknown status | NCT00081029 | Phase 3 | | 26 | Application of Botulinum Toxin Type A in Salivary Glands in the Treatment of Drooling in Patients With Cerebral Palsy | Unknown status | NCT01489904 | Phase 2, Phase 3 | | 27 | Treatment of Salivary Gland Hypofunction With Neuro- Electrostimulation | Unknown status | NCT01174329 | Phase 2, Phase 3 | | 28 | Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye | Unknown status | NCT02257957 | Phase 3 | | 29 | Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors | Unknown status | NCT01216800 | Phase 3 | | 30 | Efficacy of Tocilizumab in Primary Sjögren's Syndrome. | Unknown status | NCT01782235 | Phase 2, Phase 3 | | 31 | Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer | Unknown status | NCT00022373 | Phase 3 | | 32 | Botulinum Toxin-A for Sialorrhoea Treatment in Asian Adults With Neurological Diseases | Completed | NCT02425176 | Phase 2, Phase 3 | | 33 | Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects | Completed | NCT01994109 | Phase 3 | | 34 | Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity | Completed | NCT01652001 | Phase 2, Phase 3 | | 35 | Metoclopramide as Treatment of Clozapine-induced Hypersalivation | Completed | NCT02222220 | Phase 3 | | 36 | Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation | Completed | NCT00534573 | Phase 3 | | 37 | OGT Spray in the Management of Xerostomia in the Elderly | Completed | NCT00350350 | Phase 3 | | 38 | Tolerance and Efficacy of Rituximab in Sjogren's Disease | Completed | NCT00740948 | Phase 2, Phase 3 | | 39 | Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients | Completed | NCT00168181 | Phase 3 | | 40 | Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer | Completed | NCT00656513 | Phase 2, Phase 3 | | 41 | Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck Carcinomas | Completed | NCT00158691 | Phase 3 | | 42 | A Trial Looking at Treating Dry Mouth After Radiotherapy for Head and Neck Cancer | Completed | NCT02941276 | Phase 3 | | 43 | Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS) | Completed | NCT00125203 | Phase 2, Phase 3 | | 44 | Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions | Completed | NCT02091739 | Phase 3 | | 45 | Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome | Completed | NCT00632866 | Phase 3 | | 46 | Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions | Completed | NCT00491894 | Phase 3 | | 47 | Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older | Completed | NCT02058563 | Phase 3 | | 48 | Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome | Completed | NCT01601028 | Phase 3 | | 49 | Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases | Completed | NCT00127023 | Phase 3 | | 50 | Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases | Completed | NCT00127010 | Phase 3 |
|
